68 related articles for article (PubMed ID: 8424449)
21. Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells.
Aldinucci D; Lorenzon D; Olivo K; Rapanà B; Gattei V
Leuk Lymphoma; 2004 Sep; 45(9):1731-9. PubMed ID: 15223630
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
Pinkus GS; Lones M; Shintaku IP; Said JW
Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
[TBL] [Abstract][Full Text] [Related]
23. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.
Kadin M; Butmarc J; Elovic A; Wong D
Am J Pathol; 1993 Jan; 142(1):11-6. PubMed ID: 8424449
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease.
Newcom SR; Gu L
J Clin Pathol; 1995 Feb; 48(2):160-3. PubMed ID: 7745117
[TBL] [Abstract][Full Text] [Related]
26. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
[TBL] [Abstract][Full Text] [Related]
27. Detection of immunoglobulin light chain mRNA in nodular sclerosing Hodgkin's disease by in situ hybridization with biotinylated oligonucleotide probes compared with immunohistochemical staining with poly- and monoclonal antibodies.
Lauritzen AF; Pluzek KJ; Kristensen LE; Nielsen HW
Histopathology; 1992 Oct; 21(4):353-8. PubMed ID: 1398538
[TBL] [Abstract][Full Text] [Related]
28. High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease.
Newcom SR; Tagra KK
Cancer Res; 1992 Dec; 52(24):6768-73. PubMed ID: 1458464
[TBL] [Abstract][Full Text] [Related]
29. Correlation of histopathology with other prognostic indicators in Hodgkin's disease.
Keller AR; Kaplan HS; Lukes RJ; Rappaport H
Cancer; 1968 Sep; 22(3):487-99. PubMed ID: 5673228
[No Abstract] [Full Text] [Related]
30. Hodgkin's disease in English and African children.
Burn C; Davies JN; Dodge OG; Nias BC
J Natl Cancer Inst; 1971 Jan; 46(1):37-41. PubMed ID: 5546193
[No Abstract] [Full Text] [Related]
31. Malignant lymphoma, histiocytic type with sclerosis (sclerosing reticulum cell sarcoma).
Rosas-Uribe A; Rappaport H
Cancer; 1972 Apr; 29(4):946-53. PubMed ID: 4552814
[No Abstract] [Full Text] [Related]
32. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
[TBL] [Abstract][Full Text] [Related]
33. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.
Derynck R; Jarrett JA; Chen EY; Eaton DH; Bell JR; Assoian RK; Roberts AB; Sporn MB; Goeddel DV
Nature; 1985 Aug 22-28; 316(6030):701-5. PubMed ID: 3861940
[TBL] [Abstract][Full Text] [Related]
34. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease.
Samoszuk M; Sholly S; Epstein AL
Lab Invest; 1987 Apr; 56(4):394-400. PubMed ID: 3550288
[TBL] [Abstract][Full Text] [Related]
35. Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease.
Butterfield JH; Kephart GM; Banks PM; Gleich GJ
Blood; 1986 Dec; 68(6):1250-6. PubMed ID: 3535925
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
Ranges GE; Figari IS; Espevik T; Palladino MA
J Exp Med; 1987 Oct; 166(4):991-8. PubMed ID: 3498791
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
